March 2019 » GI CONNECT

GI CONNECT review paper published in European Journal of Cancer

by healios | Mar 26, 2019 | useful ressources

GI CONNECT review paper published in European Journal of Cancer Three GI CONNECT members authored the review paper ‘Treatment sequencing in metastatic colorectal cancer’. The paper is published in European Journal of Cancer and can be viewed here. Download the slides...

GI CONNECT Update from ASCO GI 2019

by healios | Mar 26, 2019 | gi updates

GI CONNECT Update from ASCO GI 2019 GI CONNECT has summarised the highlights from the recent ASCO GI meeting for you. Cancers of the lower GI tract by Dr. Cheng Ean Chee, National University Cancer Institute, Singapore Download the slides Cancers of the upper GI tract...

Step 1 – The SHARE Communication Framework for shared decision-making in 3rd-line treatment of metastatic colorectal cancer (mCRC)

by healios | Mar 15, 2019 | Uncategorized

Step 1 – The SHARE Communication Framework for shared decision-making in 3rd-line treatment of metastatic colorectal cancer (mCRC) Shared decision-making as best practice – Decisions are shared jointly – Patients understand that there are equivalent...

How can we understand and define re-challenge in the treatment of mCRC?

by healios | Mar 26, 2019 | your clinical answers

How can we understand and define re-challenge in the treatment of mCRC? Dr. Dominik Modest addresses the clinical question How can we understand and define re-challenge in the treatment of mCRC? Download the...

An update on flexible dosing of oral therapy in metastatic colorectal cancer (mCRC)

by healios | Mar 26, 2019 | your clinical answers

An update on flexible dosing of oral therapy in metastatic colorectal cancer (mCRC) Dr. Andrea Sartore-Bianchi and Dr. Guillem Argilés provide their views on flexible dosing of oral therapy in metastatic colorectal cancer (mCRC). Download the...

« Older Entries

GI CONNECT review paper published in European Journal of Cancer

GI CONNECT Update from ASCO GI 2019

Step 1 – The SHARE Communication Framework for shared decision-making in 3rd-line treatment of metastatic colorectal cancer (mCRC)

How can we understand and define re-challenge in the treatment of mCRC?

An update on flexible dosing of oral therapy in metastatic colorectal cancer (mCRC)

Recent Posts

Recent Comments

Archives

Categories

Meta

Thanks for visiting this website